
Vaxserve LLP
About Vaxserve LLP
Data last updated:
Vaxserve LLP is a limited liability partnership (LLP) based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 March 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAF-9381.
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Ruchir Gupta and Amit Kumar Garg.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at House No. 89 Second Floor Banarasi Dass Estate Timarpur Delhi – 110, 054, New Delhi, Delhi, India – 110054.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹11.24 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹5.47 Lakh (net margin 0.5%) and EBITDA of ₹54.7 Lakh (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 38% over five years.
As per MCA filings, the LLP has open charges of ₹3 Cr on record. Court records list 3 cases involving the LLP, including 3 filed against it; 1 case is pending.
Company details
Contact details
Vaxserve LLP's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressHouse No. 89 Second Floor Banarasi Dass Estate Timarpur Delhi – 110, 054, New Delhi, Delhi, India – 110054
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vaxserve LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Vaxserve LLP
FY 2025 filings availableVaxserve LLP reported revenue of ₹11.24 Cr (up 13% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 38% over five years, including 13% growth in the latest year. EBITDA rose 515% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹5.47 Lakh | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 0.5% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Vaxserve LLP, buy the company report.
Designated partners of Vaxserve LLP
Vaxserve has 3 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ruchir Gupta | Designated Partner | 15 Mar 2016 | 10 Years 8 Months | Current |
| Amit Kumar Garg Also directs: Toasha Biologicals LLP, Vaxserve Biotech Private Limited, Vaxserve Healthcare Private Limited and 2 more | Partner | 15 Mar 2016 | 10 Years 8 Months | Current |
| Vishal Kumar Garg Also directs: Toasha Biologicals LLP, Toasha Agencies Private Limited, Vaxserve Biotech Private Limited and 1 more | Designated Partner | 15 Mar 2016 | 10 Years 8 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Sep 2022 | 100609259 | Icici Bank Limited | ₹3 Cr | Open |
To see the full charge records of Vaxserve LLP, buy the company report.
Total charge records: 1 View all charges
Legal cases
Vaxserve LLP has 3 court cases on record: 3 filed against it. 1 case is pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 1 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed against the company by State Government | Pending |
| District court, Central, Delhi | Civil suit | Filed against the company by State | Disposed |
To see the full case history of Vaxserve LLP, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vaxserve LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Vaxserve LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Vaxserve LLP has 3 designated partner changes on record since 2016: 3 appointments. The latest: Amit Kumar Garg was appointed as Partner on 15 Mar 2016.
Frequently asked questions
Vaxserve is an active limited liability partnership based in New Delhi, Delhi, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 15 March 2016 (10+ years old) and is registered under LLPIN AAF-9381.
Vaxserve has 3 current designated partners:
- Ruchir Gupta - Designated Partner
- Amit Kumar Garg - Partner
- Vishal Kumar Garg - Designated Partner
The latest financial statements of Vaxserve on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2016 are in the company report.
The LLPIN (Limited Liability Partnership Identification Number) of Vaxserve is AAF-9381. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Vaxserve has 3 court cases on record: 3 filed against it. 1 is pending.
Vaxserve was incorporated on 15 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
Amit Kumar Garg was appointed as Partner on 15 Mar 2016. Ruchir Gupta was appointed as Designated Partner on 15 Mar 2016. Vishal Kumar Garg was appointed as Designated Partner on 15 Mar 2016.
The registered office of Vaxserve is at House No. 89 Second Floor Banarasi Dass Estate Timarpur Delhi – 110, 054, New Delhi, Delhi, India – 110054.
Vaxserve operates in the pharma industry, in the drug formulation and development segment.
Vaxserve has open charges of ₹3 Cr and no satisfied charges on record as per latest MCA filings.

